Home › Free Stock Grades › IART
Integra LifeSciences Holdings Corporation (IART) Stock Grade
IART · Healthcare
C
Market Cap
$953.3M
P/E Ratio
—
Revenue Growth (YoY)
+1.5%
Net Margin
-31.6%
Return on Equity
—
Dividend Yield
None
About Integra LifeSciences Holdings Corporation's fundamentals
Integra LifeSciences is a medical devices company with a market capitalization of $953.3 million that generated modest revenue growth of 1.5% year-over-year. The company reported a net loss in its latest annual statement, resulting in a negative net margin of -31.6%, which indicates it is currently unprofitable despite generating sales. The company does not pay a dividend to shareholders. These metrics suggest the company is in a challenging operational phase, though the positive revenue growth indicates some market demand for its products.